Daniel George On The Future Of Mhspc Treatment

Daniel George on the Future of mHSPC Treatment

GU Oncology Now

Dr. Daniel George on the Incorporation of Radium-223 in Advanced Prostate Cancer

Daniel J. George, MD, on how genomics are being incorporated into prostate cancer treatment

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Understanding Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) with Dr. Fred Saad

Future developments in the treatment of prostate cancer

The evolving treatment landscape of mHSPC and mCRPC

Dr. George on Sequential Therapy in Metastatic Prostate Cancer

How fasting and Fasting Mimicking Diet FMD affects Prostate Cancer with Dr. Valter Longo- EP-131

Dr. Geo Prostate Podcast

Prostate Cancer: Hormone Therapy Secrets Revealed! (all about Androgen Deprivation Therapy)

Healthier Through Prostate Cancer With Dr Georgios

ARASENS: the addition of darolutamide to ADT and docetaxel for the treatment of mHSPC

Managing Advanced Prostate Cancer in the Future

Evaluating triplet therapy in metastatic hormone sensitive prostate cancer

Patient Selection in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Grand Rounds in Urology

How to treat Prostate Cancer in 2024 with Dr. Rana McKay

OncBrothers: Practice-Changing Cancer Discussions

Subgroups of metastatic hormone-sensitive prostate cancer (mHSPC)

ARCHES: OS by high or low disease volume and progression to mHSPC or de novo mHSPC

Enzalutamide + ADT in Men with De Novo mHSPC: The ARCHES Trial

Grand Rounds in Urology

Metastatic prostate cancer treatment: a paradigm shift

Surgery vs Radiation Therapy! What's better for Prostate Cancer

Dr. Michael Hoffmann